Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Daily Monitor.
Press releases published on April 16, 2025
Balfour Capital Group Partners with Fundstream
EIN Presswire
·
April 16, 2025
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, April 16, 2025 /EINPresswire.com/ -- Balfour Capital Group Partners with Fundstream to Launch Institutional-Grade Real Estate Credit Investment for High-Net-Worth Individuals Balfour …
Balfour Capital Welcomes Gordon Seeto as Investment Advisor
EIN Presswire
·
April 16, 2025
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, April 16, 2025 /EINPresswire.com/ -- Balfour Capital Group Bolsters Global Strategy with Appointment of Financial Visionary Gordon Seeto Balfour Capital Group (BCG), a premier global …
Balfour Capital Welcomes Christopher Taylor as Investment Advisor - Australia
EIN Presswire
·
April 16, 2025
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, April 16, 2025 /EINPresswire.com/ -- Balfour Capital Group Welcomes Rising Talent Christopher M. Taylor, Strengthening Its Global Commitment to Excellence in Finance and Strategy …
Bongiovi Brand Unveils AI-Powered Global E-Commerce Platform
EIN Presswire
·
April 16, 2025
Blending over a century of authentic Italian flavor with cutting-edge AI technology to deliver a globally personalized digital experience RHEINFELDEN, AARGAU, SWITZERLAND, April 16, 2025 /EINPresswire.com/ -- The Bongiovi Brand, known for its premium …
Skill N Depth & Unique Group Complete First Diver Data Integration
EIN Presswire
·
April 16, 2025
Skill N Depth and Unique Group complete first real-time data transfer from Diver Control Center to digital logbook, setting a new industry benchmark. SCHINDELLEGI, SWITZERLAND, April 16, 2025 /EINPresswire.com/ -- Skill N Depth and Unique Group Achieve …
XRP News: XploraDEX $XPL Presale Sparks Frenzy With 5 Days Remaining—XRPL Traders Rush to Secure Final Allocations
GlobeNewswire
·
April 16, 2025
ZURICH, April 16, 2025 (GLOBE NEWSWIRE) -- The XploraDEX $XPL presale has officially entered its most explosive phase yet. With just 5 days remaining, traders across the XRP ecosystem are racing to grab what’s left of the rapidly vanishing allocation. What …
Liguria: nel 2024 gli acquirenti stranieri superano gli italiani nel mercato immobiliare
EIN Presswire
·
April 16, 2025
Nel 2024 il 54% delle vendite è stato effettuato da stranieri, con prezzi in crescita e forte domanda per le case di pregio in Liguria. SANREMO, LIGURIA, ITALY, April 16, 2025 /EINPresswire.com/ -- Il mercato immobiliare della Riviera di Ponente si …
Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats
GlobeNewswire
·
April 16, 2025
Allschwil, 16. April 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, gab …
Basilea shareholders approve all proposals of the board of directors at the annual general meeting
GlobeNewswire
·
April 16, 2025
Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported that shareholders …
Die Ascom Generalversammlung genehmigt alle Anträge des Verwaltungsrats
GlobeNewswire
·
April 16, 2025
Ad hoc Mitteilung gemäss Art. 53 KR Baar, Schweiz, 16. April 2025 Die Aktionärinnen und Aktionäre der Ascom Holding AG haben an der ordentlichen Generalversammlung vom 16. April 2025 in Zug allen Anträgen des Verwaltungsrats mit grosser Mehrheit …
Ascom Annual General Meeting approves all proposals of the Board of Directors
GlobeNewswire
·
April 16, 2025
Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, April 16, 2025 At the Annual General Meeting held on April 16, 2025, in Zug, the shareholders of Ascom Holding AG approved by a large majority all proposals presented by the Board of Directors. …
STMicroelectronics future-proofs the development of next-gen cars with innovative memory solution for automotive microcontrollers
GlobeNewswire
·
April 16, 2025
STMicroelectronics future-proofs the development of next-gen cars with innovative memory solution for automotive microcontrollers New Stellar microcontrollers with xMemory enable simpler, more scalable computing platform for developing software-defined …
5 Days to Go: Last Chance to Join XploraDEX Before XRP’s First AI-Powered DEX Hits the Market
GlobeNewswire
·
April 16, 2025
ZURICH, April 16, 2025 (GLOBE NEWSWIRE) -- The countdown is officially on. With just 5 days left before the close of the XploraDEX $XPL presale, investors across the crypto space are making their final moves to secure a spot in what many are calling the …
Basilea berichtet über Präsentation neuer Daten zu Fosmanogepix, Isavuconazol (Cresemba®) und Ceftobiprol (Zevtera®) auf dem Fachkongress ESCMID Global 2025
GlobeNewswire
·
April 16, 2025
Allschwil, 16. April 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, gab …
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
GlobeNewswire
·
April 16, 2025
Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today scientific …
Santhera informiert über den kommerziellen Rollout von AGAMREE®
GlobeNewswire
·
April 16, 2025
Pratteln, Schweiz, 16. April 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt den neuesten Fortschritt beim kommerziellen Rollout von AGAMREE® zur Behandlung von Duchenne-Muskeldystrophie (DMD) bekannt. Für AGAMREE zur Behandlung von Duchenne- …
Santhera shares updates on commercial rollout of AGAMREE®
GlobeNewswire
·
April 16, 2025
Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding from National Health Service (NHS) England is …